Big pharma, microdosing and inter-state commerce are among some trends to watch.
Just a few months into 2019, and it’s proving to be another wild year for the cannabis industry. More states will legalize cannabis both for medical and recreational use, and pressure is mounting on the federal government to follow suit.
Here are some trends to watch.
1. Big Pharma gets in on cannabis.
In 2018, several big-name alcohol and tobacco brands started to hedge sales losses by partnering with cannabis companies or starting their own forays into the industry. Altria, the maker of Marlboro, put $1.8 billion into Cronos Group. Constellation Brands, which produces Corona beer and dozens of other brands, invested nearly $4 billion in Canopy Growth to make a bet on cannabis-infused beverages. Taking a different approach, Heineken developed its own cannabis-infused beverage Hi-Fi Hops.
This year look for pharmaceutical companies to make strategic investments as the population ages and demand for CBD products rise. Pharma and cannabis have natural synergies. People are using CBD for dozens of conditions: Cancer, anxiety, depression, chronic pain, Parkinson’s, glaucoma, and the list goes on.
With CBD now legal in 31 states, I predict we’ll begin to see more pharmaceutical companies approaching cannabis companies for strategic partnerships. [Read More @ Entrepreneur]